论文部分内容阅读
自上皮性卵巢癌组织中提取抗原用作免疫诊断文献已有报道。我们试从这种患者腹水中提取抗原注射家兔,获得抗血清,经人全血清充分吸收后,与人全血清及正常卵巢组织抗原不起反应,而与上皮性卵巢癌组织抗原及腹水抗原起反应,从免疫电泳及双向琼脂扩散试验得到证实。以此抗血清用反向间接血凝试验检测各种患者血清289例及正常人血清143例,27例原发上皮性卵巢癌中17人阳性,占63％。临床分期中Ⅲ至Ⅳ期91.8％阳性,而Ⅰ或Ⅱ期均只有40％阳
It has been reported that antigen extraction from epithelial ovarian cancer tissue for immunodiagnosis has been reported. We try to extract antigen from ascites in this patient injected rabbits to obtain antiserum fully absorbed by human serum, with human serum and normal ovarian tissue antigen does not react, and epithelial ovarian cancer tissue antigen and ascites antigen Reactions, confirmed by immunoelectrophoresis and two-dimensional agar diffusion tests. Using this method, 289 cases of serum and 143 cases of normal serum were detected by reverse indirect hemagglutination test and 17 cases were positive in 27 cases of primary epithelial ovarian cancer, accounting for 63%. 91.8% were positive in stages Ⅲ to Ⅳ, while only 40% were positive in stage Ⅰ or Ⅱ